Low-dose naltrexone: a novel treatment for Hailey-Hailey disease.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 28991360.
- Also identified by DOI 10.1111/bjd.16045.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hailey-Hailey disease (chronic benign familial pemphigus) is a rare inherited dermatosis typically characterized by erosions at intertriginous sites preceded by minor trauma or stress. We report a case of treatment-resistant Hailey-Hailey disease having failed topical and oral steroids, prophylactic aciclovir and doxycycline, and systemic therapies including dapsone, acitretin and ciclosporin. Low-dose naltrexone 4·5 mg once daily was commenced following an incidental benefit in this patient's similarly affected sister. The clinical and psychological response to date has been considerable.
Medical subject headings
- Dermatologic Agents
- Naltrexone
- Pemphigus, Benign Familial